tiprankstipranks
Trending News
More News >
Biodesix (BDSX)
NASDAQ:BDSX
US Market

Biodesix (BDSX) Stock Forecast & Price Target

Compare
227 Followers
See the Price Targets and Ratings of:

BDSX Analyst Ratings

Strong Buy
6Ratings
Strong Buy
5 Buy
1 Hold
0 Sell
Based on 6 analysts giving stock ratings to
Biodesix
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BDSX Stock 12 Month Forecast

Average Price Target

$1.88
▲(526.67%Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Biodesix in the last 3 months. The average price target is $1.88 with a high forecast of $2.00 and a low forecast of $1.50. The average price target represents a 526.67% change from the last price of $0.30.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","1":"$1","2":"$2","3":"$3","-1":"-$1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$2.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.88,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.88</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0,1,2,3],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2024","6":"Sep<br/>2024","9":"Jan<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.53,0.6430769230769231,0.7561538461538462,0.8692307692307693,0.9823076923076923,1.0953846153846154,1.2084615384615385,1.3215384615384616,1.4346153846153846,1.5476923076923077,1.6607692307692308,1.7738461538461539,1.886923076923077,{"y":2,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.53,0.6338461538461538,0.7376923076923076,0.8415384615384616,0.9453846153846154,1.0492307692307692,1.153076923076923,1.2569230769230768,1.3607692307692307,1.4646153846153847,1.5684615384615384,1.6723076923076923,1.7761538461538462,{"y":1.88,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.53,0.6046153846153847,0.6792307692307693,0.7538461538461538,0.8284615384615385,0.9030769230769231,0.9776923076923076,1.0523076923076924,1.126923076923077,1.2015384615384614,1.2761538461538462,1.3507692307692307,1.4253846153846155,{"y":1.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.65,"date":1682899200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.65,"date":1698796800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.65,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.25,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.53,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.63,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.96,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.77,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.3,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.53,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.79,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.61,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.53,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$2.00Average Price Target$1.88Lowest Price Target$1.50
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on BDSX
TipRanks AITipRanks
Not Ranked
TipRanks
$0.5
Hold
66.67%
Upside
Reiterated
06/05/25
Biodesix faces significant financial challenges, including high leverage and negative cash flows, which weigh heavily on its stock score. While earnings call insights show revenue growth and improved efficiency, technical indicators point to a bearish trend, and poor valuation metrics reflect ongoing market concerns. The company's strategic adjustments and growth in development services offer some potential for future improvement.
Scotiabank Analyst forecast on BDSX
Sung Ji NamScotiabank
Scotiabank
$3$2
Buy
566.67%
Upside
Reiterated
05/21/25
Biodesix price target lowered to $2 from $3 at ScotiabankBiodesix price target lowered to $2 from $3 at Scotiabank
William Blair Analyst forecast on BDSX
Andrew BrackmannWilliam Blair
William Blair
Hold
Downgraded
05/14/25
William Blair downgrades Biodesix (BDSX) to a Hold
Lake Street Analyst forecast on BDSX
Thomas FlatenLake Street
Lake Street
$3$2
Buy
566.67%
Upside
Reiterated
05/14/25
Lake Street Sticks to Its Buy Rating for Biodesix (BDSX)
Canaccord Genuity Analyst forecast on BDSX
Kyle Mikson CFACanaccord Genuity
Canaccord Genuity
$2.5$1.5
Buy
400.00%
Upside
Reiterated
05/14/25
Biodesix price target lowered to $1.50 from $2.50 at CanaccordBiodesix price target lowered to $1.50 from $2.50 at Canaccord
TD Cowen
$3$2
Buy
566.67%
Upside
Reiterated
05/13/25
Analysts Are Bullish on Top Healthcare Stocks: Allogene Therapeutics (ALLO), Biodesix (BDSX)
Craig-Hallum Analyst forecast on BDSX
William BonelloCraig-Hallum
Craig-Hallum
Buy
Reiterated
05/12/25
Analysts' Top Healthcare Picks: Diamedica Therapeutics (DMAC), Cullinan Management (CGEM)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on BDSX
TipRanks AITipRanks
Not Ranked
TipRanks
$0.5
Hold
66.67%
Upside
Reiterated
06/05/25
Biodesix faces significant financial challenges, including high leverage and negative cash flows, which weigh heavily on its stock score. While earnings call insights show revenue growth and improved efficiency, technical indicators point to a bearish trend, and poor valuation metrics reflect ongoing market concerns. The company's strategic adjustments and growth in development services offer some potential for future improvement.
Scotiabank Analyst forecast on BDSX
Sung Ji NamScotiabank
Scotiabank
$3$2
Buy
566.67%
Upside
Reiterated
05/21/25
Biodesix price target lowered to $2 from $3 at ScotiabankBiodesix price target lowered to $2 from $3 at Scotiabank
William Blair Analyst forecast on BDSX
Andrew BrackmannWilliam Blair
William Blair
Hold
Downgraded
05/14/25
William Blair downgrades Biodesix (BDSX) to a Hold
Lake Street Analyst forecast on BDSX
Thomas FlatenLake Street
Lake Street
$3$2
Buy
566.67%
Upside
Reiterated
05/14/25
Lake Street Sticks to Its Buy Rating for Biodesix (BDSX)
Canaccord Genuity Analyst forecast on BDSX
Kyle Mikson CFACanaccord Genuity
Canaccord Genuity
$2.5$1.5
Buy
400.00%
Upside
Reiterated
05/14/25
Biodesix price target lowered to $1.50 from $2.50 at CanaccordBiodesix price target lowered to $1.50 from $2.50 at Canaccord
TD Cowen
$3$2
Buy
566.67%
Upside
Reiterated
05/13/25
Analysts Are Bullish on Top Healthcare Stocks: Allogene Therapeutics (ALLO), Biodesix (BDSX)
Craig-Hallum Analyst forecast on BDSX
William BonelloCraig-Hallum
Craig-Hallum
Buy
Reiterated
05/12/25
Analysts' Top Healthcare Picks: Diamedica Therapeutics (DMAC), Cullinan Management (CGEM)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Biodesix

1 Month
xxx
Success Rate
8/15 ratings generated profit
53%
Average Return
-0.97%
reiterated a xxx
rating 26 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 53.33% of your transactions generating a profit, with an average return of -0.97% per trade.
3 Months
xxx
Success Rate
5/15 ratings generated profit
33%
Average Return
-10.93%
reiterated a xxx
rating 26 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -10.93% per trade.
1 Year
Sung Ji NamScotiabank
Success Rate
1/9 ratings generated profit
11%
Average Return
-61.28%
reiterated a buy rating 19 days ago
Copying Sung Ji Nam's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -61.28% per trade.
2 Years
xxx
Success Rate
1/15 ratings generated profit
7%
Average Return
-53.77%
reiterated a xxx
rating 26 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 6.67% of your transactions generating a profit, with an average return of -53.77% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BDSX Analyst Recommendation Trends

Rating
Nov 24
Jan 25
Mar 25
Apr 25
May 25
Strong Buy
6
5
8
6
9
Buy
1
2
4
3
3
Hold
0
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
7
12
9
13
In the current month, BDSX has received 12 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. BDSX average Analyst price target in the past 3 months is 1.88.
Each month's total comprises the sum of three months' worth of ratings.

BDSX Financial Forecast

BDSX Earnings Forecast

Next quarter’s earnings estimate for BDSX is -$0.07 with a range of -$0.08 to -$0.05. The previous quarter’s EPS was -$0.08. BDSX beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year BDSX has Outperformed its overall industry.
Next quarter’s earnings estimate for BDSX is -$0.07 with a range of -$0.08 to -$0.05. The previous quarter’s EPS was -$0.08. BDSX beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year BDSX has Outperformed its overall industry.

BDSX Sales Forecast

Next quarter’s sales forecast for BDSX is $18.49M with a range of $18.00M to $19.10M. The previous quarter’s sales results were $17.96M. BDSX beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.56% of the time in the same period. In the last calendar year BDSX has Outperformed its overall industry.
Next quarter’s sales forecast for BDSX is $18.49M with a range of $18.00M to $19.10M. The previous quarter’s sales results were $17.96M. BDSX beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.56% of the time in the same period. In the last calendar year BDSX has Outperformed its overall industry.

BDSX Stock Forecast FAQ

What is BDSX’s average 12-month price target, according to analysts?
Based on analyst ratings, Biodesix’s 12-month average price target is 1.88.
    What is BDSX’s upside potential, based on the analysts’ average price target?
    Biodesix has 526.67% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is BDSX a Buy, Sell or Hold?
          Biodesix has a consensus rating of Strong Buy which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Biodesix’s price target?
            The average price target for Biodesix is 1.88. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $2.00 ,the lowest forecast is $1.50. The average price target represents 526.67% Increase from the current price of $0.3.
              What do analysts say about Biodesix?
              Biodesix’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of BDSX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis